Immunotherapy for Bladder Cancer Review With Dr. Andrea Apolo—PracticeUpdate's ESMO Coverage

Immunotherapy for Bladder Cancer Review With Dr. Andrea Apolo—PracticeUpdate's ESMO CoverageПодробнее

Bladder Cancer Innovations: ESMO 2024 Highlights w/ Dr. Andrea Apollo | BackTable Urology Ep. 193Подробнее

New Data on Immunotherapy for Bladder Cancer - Part 1Подробнее

Immunotherapy for Urothelial CancerПодробнее

Unmet needs in bladder cancer in the immunotherapy eraПодробнее

Key Takeaways from ESMO: Novel Frontline Therapies for Advanced Bladder CancerПодробнее

ESMO 2018: Immunotherapy in the Neoadjuvant Setting for Bladder CancerПодробнее

Key Takeaways from ESMO: Updates on Immunotherapy for Bladder CancerПодробнее

Novel Immunotherapy Strategies for Bladder CancerПодробнее

Dr. Andrea Apolo on Treatment Challenges in Metastatic Bladder CancerПодробнее

Biomarkers and Immunotherapy for Bladder CancerПодробнее

An Overview of Immunotherapy in Bladder Cancer.mp4Подробнее

An Overview of Immunotherapy in Bladder CancerПодробнее

Highlighting Clinical Trials: Advanced/Metastatic Bladder Cancer (Part III- Q&A)Подробнее

ESMO Dr. ApoloПодробнее

Current Research on Immunotherapy in Bladder CancerПодробнее

Promising Investigational Treatment for Bladder CancerПодробнее

Dr. Andrea Apolo on Avelumab in Metastatic Bladder CancerПодробнее

Current Research on Immunotherapy in Bladder Cancer.mp4Подробнее

AMBASSADOR: pembrolizumab for locally advanced bladder cancerПодробнее